ISR asked study sponsors, CROs, and clinical research sites what’s the most important attribute they would use to select an eCOA/ePRO provider for development-stage products. Since patients are often the ones navigating these applications, it is not surprising to see intuitiveness at the top of the list.

Data from this edition of Industry Statistics come from our report eCOA/ePRO Market Dynamics and Service Provider Performance (3rd Edition).

Originally published in Life Science Leader. View File